IgD multiple myeloma: Clinical, biological features and prognostic value of the serum free light chain assay.
Djidjik R et al. Pathol Biol (Paris). 2015 Aug 17. pii: S0369-8114(15)00057-7. doi: 10.1016/j.patbio.2015.06.002. [Epub ahead of print].
Patient dose evaluation for the whole-body low-dose multidetector CT (WBLDMDCT) skeleton study in multiple myeloma (MM).
Cretti F et al. Radiol Med. 2015 Aug 19. [Epub ahead of print].
Clinical and prognostic significance of bone marrow abnormalities in the appendicular skeleton detected by low-dose whole-body multidetector computed tomography in patients with multiple myeloma.
Nishida Y et al. Blood Cancer J. 2015 Jul 31;5:e329. doi: 10.1038/bcj.2015.57.
Morphologic and cytogenetic variables affect the flow cytometric recovery of plasma cell myeloma cells in bone marrow aspirates.
Cogbill CH et al. Int J Lab Hematol. 2015 Jul 30. doi: 10.1111/ijlh.12411. [Epub ahead of print].
Neutrophil to lymphocyte ratio (NLR) improves the risk assessment of ISS staging in newly diagnosed MM patients treated upfront with novel agents.
Romano A et al. Ann Hematol. 2015 Jul 31. [Epub ahead of print].